Literature DB >> 21269730

Macrophages from IBD patients exhibit defective tumour necrosis factor-α secretion but otherwise normal or augmented pro-inflammatory responses to infection.

Nair Campos1, Fernando Magro, Ana Rita Castro, Joana Cabral, Pedro Rodrigues, Ricardo Silva, Rui Appelberg, Susana Rodrigues, Susana Lopes, Guilherme Macedo, Amélia Sarmento.   

Abstract

Defects in macrophage function have been implicated in the establishment of Crohn's disease (CD). However, the response of macrophages from CD patients to live bacteria, particularly Mycobacterium avium subsp. paratuberculosis (MAP), has not been addressed. Considering MAP has long been associated to CD, our objective was to assess whether macrophages from CD patients showed impaired inflammatory response to infection by MAP comparing to M. avium subsp. avium (MA) and other live intestinal commensal bacteria. Human peripheral blood monocyte-derived macrophages were obtained from CD patients, ulcerative colitis (UC) patients and controls. Following in vitro infection with MAP, MA, Escherichia coli or Enterococcus faecalis, cytokine levels and cell surface receptor expression were evaluated at different time points. Macrophages from CD patients showed impaired TNF-α secretion in response to bacterial challenge, but augmented IL-23 secretion and preserved IL-12 secretion and CD-40 expression. In addition, CD macrophages showed low IL-10 secretion. Macrophages from IBD patients showed increased expression of TLR-2 and -4, unaffected by infection. Differences in cytokine secretion observed after bacterial challenge were not MAP-specific, as other bacteria (E. coli and MA) showed similar effects. Macrophages from UC patients showed a less compromised TNF-α synthesis in response to mycobacterial infection than CD macrophages, with increased constitutive IL-12 secretion, and preserved IL-10 secretion. The increased IL-23 levels in response to infection and decreased IL-10 production observed in macrophages from CD patients may contribute to the inflammatory exacerbation observed in those patients.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21269730     DOI: 10.1016/j.imbio.2011.01.002

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  19 in total

Review 1.  Macrophage-related diseases of the gut: a pathologist's perspective.

Authors:  Xavier Sagaert; Thomas Tousseyn; Gert De Hertogh; Karel Geboes
Journal:  Virchows Arch       Date:  2012-05-11       Impact factor: 4.064

Review 2.  The promise of the gut microbiome as part of individualized treatment strategies.

Authors:  Daniel A Schupack; Ruben A T Mars; Dayne H Voelker; Jithma P Abeykoon; Purna C Kashyap
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-08-27       Impact factor: 46.802

3.  Infliximab therapy increases the frequency of circulating CD16(+) monocytes and modifies macrophage cytokine response to bacterial infection.

Authors:  N Nazareth; F Magro; J Silva; M Duro; D Gracio; R Coelho; R Appelberg; G Macedo; A Sarmento
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

4.  Regulation of IL12B Expression in Human Macrophages by TALEN-mediated Epigenome Editing.

Authors:  Meng Chen; Hua Zhu; Yu-Juan Mao; Nan Cao; Ya-Li Yu; Lian-Yun Li; Qiu Zhao; Min Wu; Mei Ye
Journal:  Curr Med Sci       Date:  2020-10-29

5.  PD-L1 is required for human endometrial regenerative cells-associated attenuation of experimental colitis in mice.

Authors:  Ganggang Shi; Grace Wang; Shanzheng Lu; Xiang Li; Baoren Zhang; Xiaoxi Xu; Xu Lan; Yiming Zhao; Hao Wang
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

Review 6.  Inflammatory bowel disease: between genetics and microbiota.

Authors:  Nour Younis; Rana Zarif; Rami Mahfouz
Journal:  Mol Biol Rep       Date:  2020-02-21       Impact factor: 2.316

Review 7.  The role of macrophages and dendritic cells in the initiation of inflammation in IBD.

Authors:  Erin C Steinbach; Scott E Plevy
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325

8.  Defective tumor necrosis factor release from Crohn's disease macrophages in response to Toll-like receptor activation: relationship to phenotype and genome-wide association susceptibility loci.

Authors:  Gavin W Sewell; Farooq Z Rahman; Adam P Levine; Luke Jostins; Philip J Smith; Ann P Walker; Stuart L Bloom; Anthony W Segal; Andrew M Smith
Journal:  Inflamm Bowel Dis       Date:  2012-03-20       Impact factor: 5.325

Review 9.  The zoonotic potential of Mycobacterium avium ssp. paratuberculosis: a systematic review and meta-analyses of the evidence.

Authors:  L A Waddell; A Rajić; K D C Stärk; S A McEWEN
Journal:  Epidemiol Infect       Date:  2015-05-20       Impact factor: 4.434

Review 10.  Anti-inflammatory and antiapoptotic responses to infection: a common denominator of human and bovine macrophages infected with Mycobacterium avium subsp. paratuberculosis.

Authors:  Naiara Abendaño; Ramon A Juste; Marta Alonso-Hearn
Journal:  Biomed Res Int       Date:  2013-01-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.